Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis

Caroline Korves, Hector S. Izurieta, Jeremy Smith, Gabrielle M. Zwain, Ethan I. Powell, Abirami Balajee, Kathryn Ryder, Yinong Young-Xu
doi: https://doi.org/10.1101/2022.03.17.22272555

Article usage

Article usage: March 2022 to January 2025

AbstractFullPdf
Mar 202297746237
Apr 202234215105
May 20221761485
Jun 2022251741
Jul 2022113143
Aug 202292519
Sep 202260018
Oct 202244314
Nov 20224617
Dec 20223016
Jan 20232917
Feb 202316421
Mar 202329714
Apr 202322514
May 20231137
Jun 20231645
Jul 2023525
Aug 2023291520
Sep 202357714
Oct 20232256
Nov 20233466
Dec 20231317
Jan 2024852
Feb 20241436
Mar 2024952
Apr 20241397
May 20241224
Jun 20242095
Jul 2024946
Aug 20241132
Sep 20242559
Oct 2024863
Nov 20241039
Dec 2024747
Jan 2025112
Back to top
Posted March 30, 2022.
Download PDF
Data/Code
Email
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis
Caroline Korves, Hector S. Izurieta, Jeremy Smith, Gabrielle M. Zwain, Ethan I. Powell, Abirami Balajee, Kathryn Ryder, Yinong Young-Xu
medRxiv 2022.03.17.22272555; doi: https://doi.org/10.1101/2022.03.17.22272555
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area